Maribavir
CAY-39650-25 25 mg
Data Sheet: 
SDS:
SDS:
CAS
176161-24-3
Formulation
A solid
Purity
≥98%
MW
376,2
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
Maribavir is an antiviral agent.{24642} It inhibits human cytomegalovirus (CMV) pUL97 protein kinase (IC50 = 3 nM). Maribavir inhibits the replication of clinical isolates of CMV, including those resistant to ganciclovir (Item No. 37487), in infected MRC-5 human lung fibroblasts (IC50s = 0.03-0.13 µM). Oral administration of maribavir (25 or 75 mg/kg) decreases CMV titers in a mouse model of ocular CMV infection following implantation of human fetal retinal tissue.{66616} Formulations containing maribavir have been used in the treatment of post-transplant CMV infections.
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
